BBSRC Portfolio Analyser
Award details
Physiologically relevant modelling of the aerodigestive tract as a delivery and screening platform for drugs and bioactives
Reference
BB/R019657/1
Principal Investigator / Supervisor
Professor Jeff Pearson
Co-Investigators /
Co-Supervisors
Professor Christopher Ward
Institution
Newcastle University
Department
Biosciences Institute
Funding type
Research
Value (£)
551,322
Status
Completed
Type
Research Grant
Start date
09/06/2018
End date
08/06/2021
Duration
36 months
Abstract
unavailable
Summary
We have previously developed and made commericaly available a model of the upper digestive tract. This project will expand our modelling capability throughout the aerodigestive tract, specifically to include a lung airway model, and develop the first integrated model of the large intestine including the microbiome, mucus layer and large intestinal epithelia. In vitro systems with improved predictability allow the pharmaceutical industry to make data driven decisions early in their development pipeline, and the commercial applications for these systems are widespread and supported by the letters attached. We envisage that the first applications of these systems would be for colon and lung specific drug delivery studies, pre- and pro- biotics research, faecal transplantation studies, reflux, and host-microbiome studies. These systems will provide platforms for modelling organ specific drug delivery, disease states and interactions between these systems.
Committee
Not funded via Committee
Research Topics
Pharmaceuticals, Systems Biology
Research Priority
X – Research Priority information not available
Research Initiative
Follow-On Fund Super (SuperFOF) [2012-2015]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search